Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Bengsch

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Nature Cancer|May 14, 2025
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinomaMelissa Barroux, Jacob Househam, Eszter Lakatos, et al.
Vaccines|November 26, 2024
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple MyelomaKhalid Shoumariyeh, Benedikt Csernalabics, Elahe Salimi Alizei, et al.
Nature Communications|January 10, 2024
Prostaglandin E<sub>2</sub> controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.
Nature|July 28, 2021
Rapid and stable mobilization of CD8<sup>+</sup> T cells by SARS-CoV-2 mRNA vaccineValerie Oberhardt, Hendrik Luxenburger, Janine Kemming, et al.
Immunity|October 14, 2019
TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate DecisionZeyu Chen, Zhicheng Ji, Shin Foong Ngiow, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Prostaglandin E <sub>2</sub> controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.
Journal of Hepatology|June 8, 2023
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristicsSarp Uzun, Carl P Zinner, Amke C Beenen, et al.
Science Translational Medicine|June 12, 2024
Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activationJanaki Manoja Vinnakota, Rachael C Adams, Dimitrios Athanassopoulos, et al.
Nature Medicine|November 13, 2020
Characterization of pre-existing and induced SARS-CoV-2-specific CD8<sup>+</sup> T cellsIsabel Schulien, Janine Kemming, Valerie Oberhardt, et al.
Science Immunology|January 16, 2021
Inhibitory signaling sustains a distinct early memory CD8<sup>+</sup> T cell precursor that is resistant to DNA damageJonathan B Johnnidis, Yuki Muroyama, Shin Foong Ngiow, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Nature Cancer|May 14, 2025
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinomaMelissa Barroux, Jacob Househam, Eszter Lakatos, et al.
Vaccines|November 26, 2024
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple MyelomaKhalid Shoumariyeh, Benedikt Csernalabics, Elahe Salimi Alizei, et al.
Nature Communications|January 10, 2024
Prostaglandin E<sub>2</sub> controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.
Nature|July 28, 2021
Rapid and stable mobilization of CD8<sup>+</sup> T cells by SARS-CoV-2 mRNA vaccineValerie Oberhardt, Hendrik Luxenburger, Janine Kemming, et al.
Immunity|October 14, 2019
TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate DecisionZeyu Chen, Zhicheng Ji, Shin Foong Ngiow, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Prostaglandin E <sub>2</sub> controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.
Journal of Hepatology|June 8, 2023
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristicsSarp Uzun, Carl P Zinner, Amke C Beenen, et al.
Science Translational Medicine|June 12, 2024
Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activationJanaki Manoja Vinnakota, Rachael C Adams, Dimitrios Athanassopoulos, et al.
Nature Medicine|November 13, 2020
Characterization of pre-existing and induced SARS-CoV-2-specific CD8<sup>+</sup> T cellsIsabel Schulien, Janine Kemming, Valerie Oberhardt, et al.
Science Immunology|January 16, 2021
Inhibitory signaling sustains a distinct early memory CD8<sup>+</sup> T cell precursor that is resistant to DNA damageJonathan B Johnnidis, Yuki Muroyama, Shin Foong Ngiow, et al.
Pageof 14